Press release
Halal Pharmaceuticals Market is expected to reach USD 205.30 billion by 2034, with a CAGR of 24.39%
Halal Pharmaceuticals Market
Report Scope
The report highlights recent advancements, market share, revenue produced, leading firms in the sector, and geographical assessment of the market to provide an in-depth analysis of the halal pharmaceuticals market.
What Are Halal Pharmaceuticals?
Halal pharmaceuticals are medicines and healthcare products that adhere to Islamic principles, ensuring they are produced with permissible ingredients and processes, free from any substances or practices considered haram (forbidden) in Islam. Halal pharmaceuticals are made from ingredients derived from plants, soil, water, and animals slaughtered according to Islamic law, as well as marine animals and synthetic materials that are safe for consumers and free from impurities. Halal pharmaceuticals adhere to ethical manufacturing practices, ensuring that all aspects of the drug's development, ingredients, manufacturing, and handling comply with Islamic law. The halal pharmaceutical market is growing globally, driven by the increasing demand for halal products and the growing Muslim population.
Get Exclusive Sample Pages of This Report:
https://www.polarismarketresearch.com/industry-analysis/halal-pharmaceuticals-market/request-for-sample
Key Players in Market
The market for halal pharmaceuticals seems to be fragmented, and top market competitors are focusing on research and development to enhance their products and stimulate market demand. A few of them are:
• Alkem Laboratories Limited
• Amgen Inc.
• Bosch Pharmaceuticals
• Chemical Company of Malaysia Berhad
• EMBIL Pharmaceutical Co.
• Noor Vitamins
• Nutramedica Incorporated
• Pharmaniaga Bhd
• Rosemont Pharmaceuticals
• Simpor Pharma Sdn Bhd
Key Highlights of Halal Pharmaceuticals Market
• Based on drugs, the prescription drugs segment accounted for the largest market share in 2024, driven by the growing prevalence of chronic illnesses and the rising need for drugs with halal certification.
• Based on dosage form, the tablets & capsules segment led the market with a 50% revenue share in 2024. This is primarily attributed to the convenience, patient compliance, and accessibility of tablet and capsule administration among patients.
Request for a Discount on this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/halal-pharmaceuticals-market/request-for-discount-pricing
Growth Drivers
• Increasing awareness of environmental and health risks, including adulteration, non-compliance, and fraudulent activities in Islamic countries, is driving market growth.
• The demand for halal supplement alternatives among consumers in regions such as Indonesia and Malaysia are driving market expansion.
• The growing use of e-pharmacies and the surging demand for halal frostings are contributing to market expansion.
• The growing awareness of halal products within the Muslim community is driving revenue in the halal pharmaceuticals market.
Segmental Overview
Global Halal Pharmaceuticals Market, by Drug
5.1. Key Findings
5.2. Introduction
5.2.1. Global Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
5.3. Over-The-Counter (OTC) Drugs
5.3.1. Global Halal Pharmaceuticals Market, by Over-The-Counter (OTC) Drugs, by Region, 2020-2034 (USD Billion)
5.4. Cosmetics
5.4.1. Global Halal Pharmaceuticals Market, by Cosmetics, by Region, 2020-2034 (USD Billion)
5.5. Prescription Drugs
5.5.1. Global Halal Pharmaceuticals Market, by Prescription Drugs, by Region, 2020-2034 (USD Billion)
5.6. Nutraceuticals
5.6.1. Global Halal Pharmaceuticals Market, by Nutraceuticals, by Region, 2020-2034 (USD Billion)
5.7. Medical Devices
5.7.1. Global Halal Pharmaceuticals Market, by Medical Devices, by Region, 2020-2034 (USD Billion)
Global Halal Pharmaceuticals Market, by Dosage Form
6.1. Key Findings
6.2. Introduction
6.2.1. Global Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
6.3. Injectables
6.3.1. Global Halal Pharmaceuticals Market, by Injectables, by Region, 2020-2034 (USD Billion)
6.4. Tablets & Capsules
6.4.1. Global Halal Pharmaceuticals Market, by Tablets & Capsules, by Region, 2020-2034 (USD Billion)
6.5. Orals
6.5.1. Global Halal Pharmaceuticals Market, by Orals, by Region, 2020-2034 (USD Billion)
6.6. Topicals
6.6.1. Global Halal Pharmaceuticals Market, by Topicals, by Region, 2020-2034 (USD Billion)
6.7. Others
6.7.1. Global Halal Pharmaceuticals Market, by Others, by Region, 2020-2034 (USD Billion)
Global Halal Pharmaceuticals Market, by Therapeutic Area
7.1. Key Findings
7.2. Introduction
7.2.1. Global Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
7.3. Diabetes
7.3.1. Global Halal Pharmaceuticals Market, by Diabetes, by Region, 2020-2034 (USD Billion)
7.4. Cardiovascular Diseases
7.4.1. Global Halal Pharmaceuticals Market, by Cardiovascular Diseases, by Region, 2020-2034 (USD Billion)
7.5. Gastrointestinal Diseases
7.5.1. Global Halal Pharmaceuticals Market, by Gastrointestinal Diseases, by Region, 2020-2034 (USD Billion)
7.6. Anti-infectives
7.6.1. Global Halal Pharmaceuticals Market, by Anti-infectives, by Region, 2020-2034 (USD Billion)
7.7. Respiratory Diseases
7.7.1. Global Halal Pharmaceuticals Market, by Respiratory Diseases, by Region, 2020-2034 (USD Billion)
7.8. Neurological Diseases
7.8.1. Global Halal Pharmaceuticals Market, by Neurological Diseases, by Region, 2020-2034 (USD Billion)
7.9. Oncology
7.9.1. Global Halal Pharmaceuticals Market, by Oncology, by Region, 2020-2034 (USD Billion)
7.10. Others
7.10.1. Global Halal Pharmaceuticals Market, by Others, by Region, 2020-2034 (USD Billion)
Global Halal Pharmaceuticals Market, by Certification Type
8.1. Key Findings
8.2. Introduction
8.2.1. Global Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
8.3. Halal International Standard
8.3.1. Global Halal Pharmaceuticals Market, by Halal International Standard, by Region, 2020-2034 (USD Billion)
8.4. Gulf Standard
8.4.1. Global Halal Pharmaceuticals Market, by Gulf Standard, by Region, 2020-2034 (USD Billion)
8.5. Malaysia Standard
8.5.1. Global Halal Pharmaceuticals Market, by Malaysia Standard, by Region, 2020-2034 (USD Billion)
8.6. Others
8.6.1. Global Halal Pharmaceuticals Market, by Others, by Region, 2020-2034 (USD Billion)
Global Halal Pharmaceuticals Market, by End Users
9.1. Key Findings
9.2. Introduction
9.2.1. Global Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
9.3. Pharmacies
9.3.1. Global Halal Pharmaceuticals Market, by Pharmacies, by Region, 2020-2034 (USD Billion)
9.4. Hospitals & Clinics
9.4.1. Global Halal Pharmaceuticals Market, by Hospitals & Clinics, by Region, 2020-2034 (USD Billion)
9.5. Online Pharmacies
9.5.1. Global Halal Pharmaceuticals Market, by Online Pharmacies, by Region, 2020-2034 (USD Billion)
9.6. Retailers
9.6.1. Global Halal Pharmaceuticals Market, by Retailers, by Region, 2020-2034 (USD Billion)
9.7. Others
9.7.1. Global Halal Pharmaceuticals Market, by Others, by Region, 2020-2034 (USD Billion)
Explore The Complete Comprehensive Report Here:
https://www.polarismarketresearch.com/industry-analysis/halal-pharmaceuticals-market
Regional Analysis
• In 2024, North America represented the largest market share, influenced by the increasing Muslim population in the area and heightened consumer awareness of ingredients and sourcing.
• The halal pharmaceuticals market in Asia Pacific is expected to experience the highest growth during the forecast period, driven by the large Muslim population in the area.
• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
More Trending Latest Reports by Polaris Market Research:
Speech Therapy Services Market
https://www.polarismarketresearch.com/industry-analysis/speech-therapy-services-market
U.S. Induced Pluripotent Stem Cell (iPSC) Market
https://www.polarismarketresearch.com/industry-analysis/us-induced-pluripotent-stem-cell-ipsc-market
Europe Induced Pluripotent Stem Cell (iPSC) Market
https://www.polarismarketresearch.com/industry-analysis/europe-induced-pluripotent-stem-cell-ipsc-market
Cancer Cachexia Market
https://www.polarismarketresearch.com/industry-analysis/cancer-cachexia-market
Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Halal Pharmaceuticals Market is expected to reach USD 205.30 billion by 2034, with a CAGR of 24.39% here
News-ID: 3936988 • Views: …
More Releases from Polaris Market Research & Consulting
Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of …
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors.
Market at a Glance
In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. It…
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 …
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 3.82 billion in 2024 and is expected to…
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin …
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billion…
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 …
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 31.67 billion in 2024 and is expected to reach…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
